APA (7th ed.) Citation

Munter-Young, R., Fuentes-Alburo, A., DiGregorio, N., Neeser, K., & Gultyaev, D. (2024). Clinical and economic outcomes of adding [18F]FES PET/CT in estrogen receptor status identification in metastatic and recurrent breast cancer in the US. PLoS ONE, 19(5), 1. https://doi.org/10.1371/journal.pone.0302486

Chicago Style (17th ed.) Citation

Munter-Young, Regina, Adolfo Fuentes-Alburo, Nicholas DiGregorio, Kurt Neeser, and Dmitry Gultyaev. "Clinical and Economic Outcomes of Adding [18F]FES PET/CT in Estrogen Receptor Status Identification in Metastatic and Recurrent Breast Cancer in the US." PLoS ONE 19, no. 5 (2024): 1. https://doi.org/10.1371/journal.pone.0302486.

MLA (9th ed.) Citation

Munter-Young, Regina, et al. "Clinical and Economic Outcomes of Adding [18F]FES PET/CT in Estrogen Receptor Status Identification in Metastatic and Recurrent Breast Cancer in the US." PLoS ONE, vol. 19, no. 5, 2024, p. 1, https://doi.org/10.1371/journal.pone.0302486.